Nasal Nitric Oxide as a Non-Invasive Marker for Nasal Inflammation in Pediatric Populations
European Journal of Clinical Pharmacy · 20.12.2025 · 7 (1) · 6083-6089
DOI: 10.61336/ejcp/25-1-700 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Pharmacy, online erschienen am 20.12.2025.
Abstract (Originalsprache)
Background
Allergic rhinitis is among the most frequent chronic inflammatory diseases in young people and must be assessed with a reliable and non-invasive instrument. A possible biomarker of upper airway inflammatory process has become nasal nitric oxide (nNO).
Aim
The study had the aim of assessing nNO as a non-invasive outcome of nasal inflammation in allergic rhinitis within a pediatric population, and to determine its correlation to disease severity and treatment response. Methodology: A prospective observational research was done involving 60 children with allergic rhinitis and 40 healthy controls aged between 5 and 16 years. In the study, baseline demographic and clinical information were collected and nNO was measured with standardized chemiluminescence methods. The severity of the symptoms was measured using a valid nasal symptom score. The children with allergic rhinitis were put on four weeks of intranasal corticosteroids and nNO measurements and the symptom scores were again measured.
Results
There was a statistically significant elevated level of baseline nNO in children with allergic rhinitis versus controls and a moderate positive relationship between nNO and total nasal symptom scores and higher progression with disease severity. After treatment, nNO levels went drastically down, which was correlating with clinical symptom improvement. An analysis by age subgroups revealed that there was no significant difference in the patterns of nNO in school childhood children.
Conclusion
Nitric oxide measurement in the nose is a feasible and promising non-invasive biomarker of the presence or absence of inflammatory activity and response to therapy in allergic rhinitis in children.
Zitieren
APA
(2025). Nasal Nitric Oxide as a Non-Invasive Marker for Nasal Inflammation in Pediatric Populations. European Journal of Clinical Pharmacy, 7(1), 6083-6089. https://doi.org/10.61336/ejcp/25-1-700
Vancouver
Nasal Nitric Oxide as a Non-Invasive Marker for Nasal Inflammation in Pediatric Populations. European Journal of Clinical Pharmacy. 2025;7(1):6083-6089. doi:10.61336/ejcp/25-1-700
BibTeX
@article{euvimed2025,
title = {Nasal Nitric Oxide as a Non-Invasive Marker for Nasal Inflammation in Pediatric Populations},
journal = {European Journal of Clinical Pharmacy},
year = {2025},
volume = {7},
number = {1},
pages = {6083--6089},
doi = {10.61336/ejcp/25-1-700}
}
EUVIMED